X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
New Markets Advisory Ltd.
BSE CODE: 508867   |   NSE CODE: NA   |   ISIN CODE : INE800K01014   |   25-Mar-2026 Hrs IST
BSE NSE
Rs. 16.25
0 ( 0% )
 
Prev Close ( Rs.)
16.25
Open ( Rs.)
16.25
 
High ( Rs.)
16.25
Low ( Rs.)
16.25
 
Volume
1
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
06-Feb-2026 13-Feb-2026 Quarterly Results
24-Nov-2025 27-Nov-2025 Inter alia to consider and approve:- 1. The conversion of 37,00,000 convertible warrants into Equity Shares of face value of Rs.10/- each at par on preferential Basis to Non promoters
10-Nov-2025 14-Nov-2025 Quarterly Results
07-Aug-2025 14-Aug-2025 Quarterly Results
26-Jun-2025 02-Jul-2025 Preferential Issue of shares (Revised) The Board Meeting to be held on 27/06/2025 has been revised to 02/07/2025
20-Jun-2025 27-Jun-2025 Preferential Issue of shares & Inter alia, to consider and approve :- 1. Proposal for issue of 0% Convertible Equity Warrants on a preferential basis to certain identified non-promoter persons/entities and preferential allotment of equity shares to non-promoters, subject to such approvals as may be required, including that of shareholders and regulatory authorities; 2. Appointment of Director on the Board of the Company; 3. Convening of the 43rd Annual General Meeting (AGM) of the Company and to finalize the date, time, and venue for the same; 4. Any other matter with the permission of the Chairman.
16-Apr-2025 24-Apr-2025 Preferential Issue of shares & Increase in Authorised Capital & Audited Results Inter alia, proposes the following key resolutions to pass: 1. Discussion on raising fund through Preferential Issue. 2. Increase in Authorized share capital of the Company. 3, Director appointment and resignation. 4. Discussion on Change of Name of the Company. 5. Discussion on Change of Object of the Company. 6. Adoption of the Audited Financials of the Company for Quarter ended 31 March, 2025 and year ended 2024-2025. 7. Any other business with the permission of Chairperson.
05-Feb-2025 12-Feb-2025 Quarterly Results
02-Dec-2024 09-Dec-2024 Inter alia, to consider the following agenda items: 1. Increase in the authorized share capital of the Company, subject to the approval of members at the ensuing general meeting. 2. Discussion and approval of amendments to the Capital Clause and Object Clause of the Memorandum of Association for the increase in authorized share capital and modification of the Object Clause, subject to shareholder approval. 3. Approval for an increase in the limits for granting loans, making investments, and providing guarantees under Section 186 of the Companies Act, 2013. 4. Approval for an increase in the borrowing limits under Section 180(1)(c) of the Companies Act, 2013. 5. Discussion on an initial investment proposal involving the acquisition of equity shares of another company, subject to valuation, due diligence, and determining the mode of acquisition. 6. Consideration and approval of fund-raising proposals through the issuance of Equity Shares by permissible modes (Preferential Issue/Right Issue/CCPS/CCD), as deemed appropriate by the Board. 7. Appointment of requisite intermediaries (Valuer/Consultants) for the above-mentioned nvestment activities
05-Nov-2024 13-Nov-2024 Quarterly Results
Page 1 of 12
PREV || NEXT